"Flecainide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
Descriptor ID |
D005424
|
MeSH Number(s) |
D03.383.621.270
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Flecainide".
Below are MeSH descriptors whose meaning is more specific than "Flecainide".
This graph shows the total number of publications written about "Flecainide" by people in this website by year, and whether "Flecainide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2005 | 0 | 1 | 1 |
2007 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Flecainide" by people in Profiles.
-
"Second line medications" for supraventricular arrhythmias in children: In-hospital efficacy and adverse events during treatment initiation of sotalol and flecainide. J Cardiovasc Electrophysiol. 2021 08; 32(8):2207-2215.
-
A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide. Indian Heart J. 2020 Sep - Oct; 72(5):383-388.
-
Localized basal left ventricular dyssynchrony induced by manifest accessory pathway: Successful differentiation from cardiac involvement of sarcoidosis with administration of flecainide acetate. J Electrocardiol. 2019 Nov - Dec; 57:87-89.
-
Flecainide Toxicity Resulting in Pacemaker Latency and Intermittent Failure to Capture. Am J Case Rep. 2019 Aug 30; 20:1279-1283.
-
Flecainide-Induced Left Ventricular Dysfunction: Fact or Fiction? Cardiovasc Toxicol. 2017 10; 17(4):494-495.
-
Proarrhythmic Antiarrhythmic. Tex Heart Inst J. 2016 Dec; 43(6):507-508.
-
In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia. J Physiol. 2016 Feb 01; 594(3):567-93.
-
Flecainide use in children with cardiomyopathy or structural heart disease. Pediatr Cardiol. 2015 Jan; 36(1):146-50.
-
Life-threatening flecainide intoxication in a young child secondary to medication error. Ann Pharmacother. 2009 Sep; 43(9):1522-7.
-
Flecainide for the treatment of chronic neuropathic pain: a Phase II trial. Palliat Med. 2007 Dec; 21(8):667-72.